Insiders Novartis AG

Equities

NOVN

CH0012005267

Pharmaceuticals

Market Closed - Swiss Exchange Other stock markets 11:31:52 2026-05-21 EDT			5-day change	1st Jan Change
119.24 ^CHF	+0.59%		+2.09%	+8.80%

04:06am	Can Bayer Still Recover?
01:19am	Novartis: Pluvicto psmaddition data to highlight efficacy in metastatic hormone-sensitive prostate cancer	RE

Insiders

03-06	Novartis Shareholders Approve Dividend Raise, Share Capital Reduction	MT
03-06	Novartis AG Approves Board and Committee Appointments	CI
03-06	Novartis Shareholders Re-elect Board Chair	MT
02-20	Novartis Price Target Up as AlphaValue/Baader Europe Notes FY25 Results, 'Healthy' Balance Sheet	MT
01-13	Swiss stocks - Factors to watch on January 13	RE
25-07-17	Novartis Announces Executive Committee Changes	CI
25-07-17	Novartis Names Mukul Mehta as Finance Chief	MT
25-07-17	Pharmaceutical Giant Novartis Names New CFO	MT
25-07-17	Novartis appoints Mukul Mehta as chief financial officer, as Harry Kirsch retires after 22 years with the company	RE
25-05-05	BioNTech Names Novartis Executive as New CFO	MT
25-05-05	BioNTech says Novartis executive Zapata-Gomez to become CFO	RE
25-05-05	BioNTech says Novartis executive Zapata-Gomez to become CFO	RE
25-03-31	Novartis Adds Compliance Function to Chief Legal Officer Role	MT
25-03-31	Novartis Appoints Karen Hale Chief Legal And Compliance Officer	RE
25-03-31	Novartis Announces Executive Changes	CI
25-03-30	Novartis appoints Karen Hale, Chief Legal and Compliance Officer, as Klaus Moosmayer, Chief Ethics, Risk & Compliance Officer, steps down from the Executive Committee of Novartis	DJ
25-03-14	Novartis Named Official Pharmaceutical Partner of US' National Football League	MT
25-03-07	Novartis AG Approves Board Changes	CI
25-02-26	Novartis Stockholder Sandoz to Reportedly Sell 26.5 Million Shares	MT
25-02-11	PRESS DIGEST-Financial Times - February 12	RE
25-01-21	Novartis CEO Says They Will Have to 'Tackle Rhetoric' in US Healthcare	MT
24-07-18	Novartis AG Announces That Charles L. Sawyers and William T. Winters Will Not Stand for Re-Election	CI
24-07-18	Novartis raises 2024 profit guidance for second time	RE
24-04-23	Vas Narasimhan, CEO of Novartis: 40% margin by 2027	MT
24-04-23	Novartis Nominates Former Bristol Myers Squibb CEO as New Chair	MT